Gene · 10278
Papers1,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A ROS and pH dual - responsive hydrogel-nanoparticle system restores intervertebral disc and alleviates related pain by modulating senescence and panoptosis of nucleus pulposus cells. | Mater Today Bio | 2026 | 41716350 | PubTator, text mining | PubMed |
| Investigating the epigenetic modulating potential of gallic acid during ethanol-induced toxicity: In silico and in vitro approaches. | Bioorg Chem | 2026 | 41653680 | PubTator, text mining | PubMed |
| PTUPB, a soluble epoxide hydrolase/cyclooxygenase‑2 dual inhibitor, reduces endothelial‑to‑mesenchymal transition and improves doxorubicin‑induced vascular and cardiac toxicity. | Mol Med Rep | 2026 | 41614417 | PubTator, text mining | PubMed |
| NF-κB activation as a pro-survival signal from pharmacological inhibition of pyruvate dehydrogenase kinase 1 in non-small-cell lung carcinoma cell models. | Transl Oncol | 2026 | 41570465 | PubTator, text mining | PubMed |
| A systematic review of the neurobiological mechanisms of chemotherapy-induced deficits in executive functions. | Brain Behav Immun Health | 2026 | 41561477 | PubTator, text mining | PubMed |
| Preventive effects of Dendrobium hybrid extract on free radical activity and melanoma cell proliferation by inducing apoptotic gene expression. | Biomed Rep | 2026 | 41384132 | PubTator, text mining | PubMed |
| Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia. | ASPET Discov | 2025 | 42422326 | PubTator, text mining | PubMed |
| Small molecule-mediated spatial targeting of mitochondria and the Golgi apparatus in cancer cells. | RSC Med Chem | 2025 | 41561072 | PubTator, text mining | PubMed |
| The Status and Emerging Developments in Laboratory Animal Science in Asia since 9th AFLAS Congress (2023) until 10th AFLAS Congress (2025). | Animal Model Exp Med | 2025 | 41540565 | PubTator, text mining | PubMed |
| CRISPR-Cas systems against carbapenem resistance: from proof-of-concept to clinical translation. | Front Microbiol | 2025 | 41488303 | PubTator, text mining | PubMed |
| The protective effects of dapagliflozin on cisplatin-induced ovarian toxicity via NRF2-HO-1 pathway and TNF-α/Cas3 signaling. | Sci Rep | 2025 | 41365938 | PubTator, text mining | PubMed |
| Development and validation of a multidimensional tool for baseline functional phenotyping in cardiac rehabilitation. | BMC Cardiovasc Disord | 2025 | 41345559 | PubTator, text mining | PubMed |
| Possible TLR-mediated immunostimulatory effect of Palbociclib in breast cancer. | Mol Biol Rep | 2025 | 41296105 | PubTator, text mining | PubMed |
| Selinexor, a selective inhibitor of nuclear export, shows anti-proliferative and anti-migratory effects on male germ cells in vitro. | BMC Pharmacol Toxicol | 2025 | 41286980 | PubTator, text mining | PubMed |
| The influence of specific cognitive training in virtual reality on the inhibition of elite young ice hockey players. | Front Sports Act Living | 2025 | 41245651 | PubTator, text mining | PubMed |
| Halotolerant Endophytic Fungi: Diversity, Host Plants, and Mechanisms in Plant Salt-Alkali Stress Alleviation. | Plants (Basel) | 2025 | 41012059 | PubTator, text mining | PubMed |
| CRISPR-driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges. | Clin Transl Med | 2025 | 41000010 | PubTator, text mining | PubMed |
| Fueling chromosomal gene diversification and artificial evolution with CRISPR. | Genome Biol | 2025 | 40988083 | PubTator, text mining | PubMed |
| Enhancement of second-harmonic generation through Brillouin zone folding in a waveguide-coupled metasurface. | Nanophotonics | 2025 | 40970241 | PubTator, text mining | PubMed |
| The fungal STRIPAK complex: Cellular conductor orchestrating growth and pathogenicity. | PLoS Pathog | 2025 | 40953055 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10278/papers?page=2